4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Background

          Plasmodium vivax malaria is challenging to control and eliminate. Treatment with radical cure drugs fails to target the hidden asymptomatic and hypnozoite reservoirs in populations. PvSeroTAT, a novel serological test-and-treat intervention using a serological diagnostic to screen hypnozoite carriers for radical cure eligibility and treatment, could accelerate P. vivax elimination.

          Methods

          Using a previously developed mathematical model of P. vivax transmission adapted to the Brazilian context as a case study for implementation, we evaluate the public health impact of various deployment strategies of PvSeroTAT as a mass campaign. We compare relative reductions in prevalence, cases averted, glucose-6-phosphate dehydrogenase (G6PD) tests, and treatment doses of PvSeroTAT campaigns to strengthened case management alone or mass drug administration (MDA) campaigns across different settings.

          Findings

          Deploying a single round of PvSeroTAT with 80% coverage to treat cases with a high efficacy radical cure regimen with primaquine is predicted to reduce point population prevalence by 22.5% [95% UI: 20.2%–24.8%] in a peri-urban setting with high transmission and by 25.2% [95% UI: 9.6%–42.2%] in an occupational setting with moderate transmission. In the latter example, while a single PvSeroTAT achieves 9.2% less impact on prevalence and averts 300 less cases per 100,000 than a single MDA (25.2% [95% UI: 9.6%–42.2%] point prevalence reduction versus 34.4% [95% UI: 24.9%–44%]), PvSeroTAT requires 4.6 times less radical cure treatments and G6PD tests. Layering strengthened case management and deploying four rounds of PvSeroTAT six months apart is predicted to reduce point prevalence by a mean of 74.1% [95% UI: 61.3%–86.3%] or more in low transmission settings with less than 10 cases per 1000 population.

          Interpretation

          Modelling predicts that mass campaigns with PvSeroTAT are predicted to reduce P. vivax parasite prevalence across a range of transmission settings and require fewer resources than MDA. In combination with strengthened case management, mass campaigns of serological test-and-treat interventions can accelerate towards P. vivax elimination.

          Funding

          This project was funded in part by the doi 10.13039/100000865, Bill and Melinda Gates Foundation; and the doi 10.13039/501100000925, National Health and Medical Research Council; .

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Malaria in Brazil: an overview

          Malaria is still a major public health problem in Brazil, with approximately 306 000 registered cases in 2009, but it is estimated that in the early 1940s, around six million cases of malaria occurred each year. As a result of the fight against the disease, the number of malaria cases decreased over the years and the smallest numbers of cases to-date were recorded in the 1960s. From the mid-1960s onwards, Brazil underwent a rapid and disorganized settlement process in the Amazon and this migratory movement led to a progressive increase in the number of reported cases. Although the main mosquito vector (Anopheles darlingi) is present in about 80% of the country, currently the incidence of malaria in Brazil is almost exclusively (99,8% of the cases) restricted to the region of the Amazon Basin, where a number of combined factors favors disease transmission and impair the use of standard control procedures. Plasmodium vivax accounts for 83,7% of registered cases, while Plasmodium falciparum is responsible for 16,3% and Plasmodium malariae is seldom observed. Although vivax malaria is thought to cause little mortality, compared to falciparum malaria, it accounts for much of the morbidity and for huge burdens on the prosperity of endemic communities. However, in the last few years a pattern of unusual clinical complications with fatal cases associated with P. vivax have been reported in Brazil and this is a matter of concern for Brazilian malariologists. In addition, the emergence of P. vivax strains resistant to chloroquine in some reports needs to be further investigated. In contrast, asymptomatic infection by P. falciparum and P. vivax has been detected in epidemiological studies in the states of Rondonia and Amazonas, indicating probably a pattern of clinical immunity in both autochthonous and migrant populations. Seropidemiological studies investigating the type of immune responses elicited in naturally-exposed populations to several malaria vaccine candidates in Brazilian populations have also been providing important information on whether immune responses specific to these antigens are generated in natural infections and their immunogenic potential as vaccine candidates. The present difficulties in reducing economic and social risk factors that determine the incidence of malaria in the Amazon Region render impracticable its elimination in the region. As a result, a malaria-integrated control effort - as a joint action on the part of the government and the population - directed towards the elimination or reduction of the risks of death or illness, is the direction adopted by the Brazilian government in the fight against the disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised Placebo-Controlled Trial and Mathematical Model

            Background The undetectable hypnozoite reservoir for relapsing Plasmodium vivax and P. ovale malarias presents a major challenge for malaria control and elimination in endemic countries. This study aims to directly determine the contribution of relapses to the burden of P. vivax and P. ovale infection, illness, and transmission in Papua New Guinean children. Methods and Findings From 17 August 2009 to 20 May 2010, 524 children aged 5–10 y from East Sepik Province in Papua New Guinea (PNG) participated in a randomised double-blind placebo-controlled trial of blood- plus liver-stage drugs (chloroquine [CQ], 3 d; artemether-lumefantrine [AL], 3 d; and primaquine [PQ], 20 d, 10 mg/kg total dose) (261 children) or blood-stage drugs only (CQ, 3 d; AL, 3 d; and placebo [PL], 20 d) (263 children). Participants, study staff, and investigators were blinded to the treatment allocation. Twenty children were excluded during the treatment phase (PQ arm: 14, PL arm: 6), and 504 were followed actively for 9 mo. During the follow-up time, 18 children (PQ arm: 7, PL arm: 11) were lost to follow-up. Main primary and secondary outcome measures were time to first P. vivax infection (by qPCR), time to first clinical episode, force of infection, gametocyte positivity, and time to first P. ovale infection (by PCR). A basic stochastic transmission model was developed to estimate the potential effect of mass drug administration (MDA) for the prevention of recurrent P. vivax infections. Targeting hypnozoites through PQ treatment reduced the risk of having at least one qPCR-detectable P. vivax or P. ovale infection during 8 mo of follow-up (P. vivax: PQ arm 0.63/y versus PL arm 2.62/y, HR = 0.18 [95% CI 0.14, 0.25], p < 0.001; P. ovale: 0.06 versus 0.14, HR = 0.31 [95% CI 0.13, 0.77], p = 0.011) and the risk of having at least one clinical P. vivax episode (HR = 0.25 [95% CI 0.11, 0.61], p = 0.002). PQ also reduced the molecular force of P. vivax blood-stage infection in the first 3 mo of follow-up (PQ arm 1.90/y versus PL arm 7.75/y, incidence rate ratio [IRR] = 0.21 [95% CI 0.15, 0.28], p < 0.001). Children who received PQ were less likely to carry P. vivax gametocytes (IRR = 0.27 [95% CI 0.19, 0.38], p < 0.001). PQ had a comparable effect irrespective of the presence of P. vivax blood-stage infection at the time of treatment (p = 0.14). Modelling revealed that mass screening and treatment with highly sensitive quantitative real-time PCR, or MDA with blood-stage treatment alone, would have only a transient effect on P. vivax transmission levels, while MDA that includes liver-stage treatment is predicted to be a highly effective strategy for P. vivax elimination. The inclusion of a directly observed 20-d treatment regime maximises the efficiency of hypnozoite clearance but limits the generalisability of results to real-world MDA programmes. Conclusions These results suggest that relapses cause approximately four of every five P. vivax infections and at least three of every five P. ovale infections in PNG children and are important in sustaining transmission. MDA campaigns combining blood- and liver-stage treatment are predicted to be a highly efficacious intervention for reducing P. vivax and P. ovale transmission. Trial registration ClinicalTrials.gov NCT02143934
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Factors determining the occurrence of submicroscopic malaria infections and their relevance for control

              Measuring the prevalence of malaria infection in population surveys underpins surveillance and control of the parasite. During more than a century of malaria research, parasite infection has been assessed by light microscopy of blood films. This wealth of data is widely used to understand malaria epidemiology, to monitor and inform control strategy1, to map the geographical distribution of malaria over time2 and to aid development of mathematical models. Rapid diagnostic tests (RDTs) based on antigen detection are now also used for prevalence surveys. However, both techniques have limited sensitivity. Molecular detection techniques for malaria3 have a much higher sensitivity and are increasingly revealing the widespread presence of infections with parasite densities below the detection threshold of either microscopy or RDTs. These results fundamentally challenge our current view of malaria epidemiology and burden of infection. In a previous systematic review and meta-analysis we found that microscopy misses on average half of all Plasmodium falciparum infections in endemic areas compared with PCR4. There was high variability between surveys and transmission settings. It remains unclear what factors cause this variation in levels of submicroscopic infections, and to what extent such infections are relevant to current efforts to control and eliminate the parasite. From a clinical perspective, low-density infection has been associated with mild anaemia5 and adverse effects during pregnancy6, but rarely causes acute symptoms. Nevertheless, the public health importance of low-density infections may be significant, as experiments have shown that mosquitoes feeding on individuals who are parasite-negative by microscopy can become infected with malaria7 8. The probability of detecting malarial infection is a function of the density of parasites and the volume of blood examined. Parasite densities in the peripheral blood fluctuate considerably over the course of any single P. falciparum infection and may dip under the microscopic detection threshold9 due to sequestration during the second half of the 48 h life cycle and varying effectiveness of the host's immune response. The volume of blood examined during microscopy slide-reading, if 100 high-power fields are screened, is 0.1–0.25 μl (refs 10, 11, 12), whereas for PCR detection DNA is extracted from 5 to 100 μl in most commonly used protocols. On the basis of these volumes, the theoretical detection limit for standard thick film microscopy is approximately 4–10 parasites per μl, and for PCR it is 0.01–0.2 parasites per μl. In practice, a low number of parasitized red blood cells in a sample is often not sufficient to enable detection due to technical factors such as loss of parasites during staining of microscopy slides10 13 or use of single versus nested PCR protocols. Calibration against cultures with known parasite densities has shown realistic detection limits of 10–100 parasites per μl for microscopy14 and 0.05–10 parasites per μl for various PCR assays15 16. From the perspective of control agencies aiming to reduce transmission, the most important question is to what extent do submicroscopic parasite carriers, who are missed during routine surveys, contribute to sustaining transmission? To become infected with malaria, Anopheles vectors need to take up a minimum of one male and one female gametocyte in a 2- to 3-μl bloodmeal. There is still a considerable probability of this happening at parasite densities that will often be missed by microscopy (for example, 1–10 parasites per μl), both according to mathematical theory and data17, and an aggregated distribution of parasites in the blood may assist transmission at very low densities18. During the scale-up of malaria control, public health agencies must decide what screening tools to use in different populations and whether submicroscopic carriers are a priority for intervention19. With sufficient resources, submicroscopic parasites could be detected in active screening programmes20 and included in evaluations where they may alter estimates of how interventions impact the prevalence of infection. Both from a biological and a public health perspective, it is important to understand where and when submicroscopic carriage is mostly likely to occur. Here we compile and analyse epidemiological data sets to assess firstly the prevalence of submicroscopic parasite carriers, and secondly which factors cause these carriers to be more numerous in some areas and population groups. We explore the roles of immunity, anti-malarial treatment, level of malaria endemicity and technical test performance. On the basis of 106 PCR prevalence surveys, we develop an analysis tool to estimate how prevalent such carriers are likely to be in any given area. We estimate the contribution of submicroscopic parasite carriers to the onward transmission of malaria by combining survey data with human-to-mosquito transmission studies. Results Submicroscopic parasitaemia across the endemicity spectrum We compiled survey data in which P. falciparum prevalence was measured by both microscopy and by PCR in the same individuals through updating a previous systematic review4. One hundred and six surveys met our inclusion criteria for analysis, taking place in endemic populations within a defined geographic area where participants were not selected according to malaria symptoms or test results, and where nested PCR or equivalent was used for parasite detection (see also Methods and Supplementary Table S1). Submicroscopic carriers were defined as those individuals with infections detected by PCR but not by microscopy. The specificity of microscopy relative to PCR is very high (98.4% on average4), and given infrequent reporting of specificity in the included studies we assume in our analysis that slide-positive results are also PCR-positive. Microscopy detected, on average, 54.1% (95% confidence interval (CI), 50.3–58.2%) of all PCR-detected infections across the 106 surveys, but this sensitivity varied widely (Fig. 1a) as in previous analysis4. Regression analysis showed that the PCR prevalence of infection has a strong linear relationship with microscopy prevalence on the log odds scale (Fig. 1a). Stratifying by age group improved the fit to the data with microscopy sensitivity being higher in children only ( 200) so that measures were representative of an average infection. Other human infectiousness studies We searched the literature to find as many studies as possible measuring human-to-mosquito transmission from individuals in malaria-endemic areas with neither asexual parasites nor gametocytes detectable by microscopy, using PubMed and modern transmission studies17 31 as starting points and searching through the relevant literature using bibliographies and a review8. We identified three further relevant studies in addition to the malaria therapy data. One of these directly measured submicroscopic parasitaemia using quantitative nucleic acid sequence-based amplification as well as slide positivity31. Two further human-to-mosquito transmission experiments measured the infectiousness of slide-negative individuals, but their infection status was not tested by molecular methods7 30. We estimated the PCR prevalence in these study populations using the log linear model described in the main text (equation 1, Fig. 1a) and the reported slide prevalence in the study. The prevalence of submicroscopic carriage was calculated as: We assumed all infections from slide negatives arose from these submicroscopic carriers, using them as the denominator in calculating infectiousness. The contribution of slide-positives or submicroscopic carriers to the infectious reservoir was calculated as: The proportion of mosquito infections which would originate from submicroscopic infections was estimated as: Age-prevalence data We extracted the data from all studies which included children and adults and which gave a breakdown of prevalence by microscopy and PCR for at least three age groups. We fit a linear relationship between microscopy sensitivity and age, using the midpoint of the age group, and tested whether underlying population PCR prevalence was a modifying factor. Here we used log prevalence ratios, as log ORs of microscopy: PCR positivity would decline as PCR prevalence increased, even with constant sensitivity in all settings. Author contributions L.C.O. updated the systematic review, did the analysis and drafted the manuscript, T.B. reviewed the studies and collected data, J.T.G. advised and contributed to the analysis, A.L.O. contributed data. All authors contributed to interpretation of data, writing and revising the manuscript, and have seen and approved the final version. Additional information How to cite this article: Okell, L. C. et al. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat. Commun. 3:1237 doi: 10.1038/ncomms2241 (2012). Supplementary Material Data sources and references Supplementary Table S1 and Supplementary References Prevalence estimation tool Spreadsheet permitting estimation of PCR prevalence from microscopy slide prevalence and vice-versa
                Bookmark

                Author and article information

                Contributors
                Journal
                Lancet Reg Health Am
                Lancet Reg Health Am
                Lancet Regional Health - Americas
                Elsevier
                2667-193X
                19 May 2023
                June 2023
                19 May 2023
                : 22
                : 100511
                Affiliations
                [a ]Institut Pasteur, Université Paris Cité, G5 Épidémiologie et Analyse des Maladies Infectieuses, Paris, France
                [b ]Swiss Tropical and Public Health Institute, Allschwil, Switzerland
                [c ]University of Basel, Basel, Switzerland
                [d ]Institut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, Paris, France
                [e ]Escola Superior de Ciências da Saúde, Universidade do Estado do Amazonas, Manaus, Brazil
                [f ]Diretoria de Ensino e Pesquisa, Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil
                [g ]Instituto Leônidas e Maria Deane, Fundação Oswaldo Cruz, Manaus, Brazil
                [h ]Population Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
                [i ]Department of Medical Biology, University of Melbourne, Melbourne, Australia
                Author notes
                []Corresponding author. Swiss Tropical and Public Health Institute, Allschwil, Switzerland. narimane.nekkab@ 123456swisstph.ch
                Article
                S2667-193X(23)00085-6 100511
                10.1016/j.lana.2023.100511
                10209700
                37250687
                8fa9fc35-e113-4dcb-a7c1-3336e55b8d07
                © 2023 The Author(s)

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 2 February 2023
                : 5 April 2023
                : 4 May 2023
                Categories
                Articles

                plasmodium vivax,malaria,mathematical modelling,serological diagnostics,radical cure,elimination,mass screening,treatment

                Comments

                Comment on this article